Sab Biotherapeutics Inc (SABS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SABS | QTTB | ESLA | ||
| Company | Sab Biotherapeutics Inc | Q32 Bio Inc | Estrella Immunopharma Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.67 | 3.58 | 1.1800 | ||
| High | 4.74 | 3.73 | 1.1800 | ||
| Low | 4.17 | 3.37 | 1.0800 | ||
| Last | 4.52 | 3.43 | 1.0800 | ||
| Change | -0.13 | -0.16 | -0.0800 | ||
| % Change | -2.80% | -4.46% | -6.90% | ||
| Volume | 20,945 | 100,432 | 1,046 | ||
| 20-Day Average Volume | 93,910 | 669,242 | 57,732 | ||
| Previous Close | 4.65 | 3.59 | 1.1600 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 3.57 | 15.56 | 1.1914 | ||
| 20-Day Raw Stochastic | 68.89% | 1.51% | 31.93% | ||
| 20-Day Relative Strength | 57.68% | 19.82% | 49.61% | ||
| Weighted Alpha | -38.42 | +3.66 | -9.39 | ||
| Today's Opinion | 72% Buy | 72% Sell | 8% Sell | ||
| Previous Opinion | 72% Buy | 72% Sell | 24% Buy | ||
| Last Month's Opinion | 8% Buy | 8% Sell | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.76% since 12/16/24 | -2.66% since 12/16/24 | -14.96% since 12/16/24 | ||
| Low | 3.32 on 12/18/24 | 3.02 on 12/18/24 | 1.0200 on 12/19/24 | ||
| High | 4.70 on 12/20/24 | 3.77 on 12/20/24 | 1.4100 on 12/17/24 | ||
| 1-Month | |||||
| %Chg | +37.60% since 11/22/24 | -86.12% since 11/22/24 | +18.68% since 11/22/24 | ||
| Low | 2.75 on 12/05/24 | 3.02 on 12/18/24 | 0.8900 on 11/25/24 | ||
| High | 5.01 on 12/09/24 | 28.66 on 11/27/24 | 1.4850 on 12/09/24 | ||
| 3-Month | |||||
| %Chg | +43.56% since 09/23/24 | -92.20% since 09/23/24 | +11.34% since 09/23/24 | ||
| Low | 2.36 on 10/15/24 | 3.02 on 12/18/24 | 0.6300 on 10/31/24 | ||
| High | 5.01 on 12/09/24 | 53.17 on 10/25/24 | 1.5500 on 09/27/24 | ||
| 6-Month | |||||
| %Chg | +51.65% since 06/21/24 | -78.01% since 06/21/24 | +14.80% since 06/21/24 | ||
| Low | 2.16 on 08/14/24 | 3.02 on 12/18/24 | 0.6300 on 10/31/24 | ||
| High | 5.01 on 12/09/24 | 53.79 on 09/11/24 | 3.2300 on 07/26/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 42,916 | 43,730 | 41,968 | ||
| Shares Outstanding, K | 9,229 | 12,181 | 36,179 | ||
| Annual Sales | 2,240,000 | 1,160,000 | 0 | ||
| Annual Net Income | -42,190,000 | -112,960,000 | -7,310,000 | ||
| Last Quarter Sales | 260,000 | 0 | 0 | ||
| Last Quarter Net Income | -7,340,000 | -17,600,000 | -3,380,000 | ||
| 60-Month Beta | 0.59 | -0.46 | 0.46 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.12 on 11/06/24 | -1.46 on 11/07/24 | -0.09 on 11/14/24 | ||
| Latest Earnings Date | 11/11/24 | 11/12/24 | 02/12/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||